Pharma Deprée SRL
Pharma Deprée reported total assets of 940,273 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026).
The score of Pharma Deprée shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +53 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Deprée's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 67,217 € | ||||
| Equity | 257,179 € | ||||
| Cash | 63,239 € | ||||
| EBITDA | 111,863 € | ||||
| Total assets | 940,273 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Pharma Deprée's financial analysis
- Solvency27.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Deprée
Pharma Deprée's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0692.655.719
- VAT number
- BE0692655719
- Peppol
- Registered · 0208:0692655719 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Mar 2018
- Registered office
- 3120 Tremelo
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
Pharma Deprée (SRL) has been based in Tremelo since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 67,217 € and equity of 257,179 €; its revenue is not published. Its solvency stands at 27.4%, below the median of its sector (55.6%).
Companies similar to Pharma Deprée
Companies in the same business, of comparable size and area, outside its group.
- Arenaria Activities of holding companies Ghent · balance sheet 940,130 €
- Pharminackx Activities of holding companies Alken · balance sheet 940,417 €
- W & G Invest Activities of holding companies Genk · balance sheet 939,673 €
- Genesis Enterprise Activities of holding companies Antwerp · balance sheet 937,935 €
- Narwal Activities of holding companies Heusden-Zolder · balance sheet 942,650 €
- B.N.V. Activities of holding companies Lummen · balance sheet 937,842 €
- Fine Flavours Holding Activities of holding companies Bilzen-Hoeselt · balance sheet 942,884 €
- Cobalt Industries Activities of holding companies Leuven · balance sheet 943,556 €
Frequently asked questions about Pharma Deprée
What is the revenue of Pharma Deprée?
Pharma Deprée files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Deprée?
In Belgium, the VAT number is the company number prefixed with BE: BE0692655719 for Pharma Deprée, if the company is VAT-registered. Its company number (CBE) is 0692.655.719.
Where is the registered office of Pharma Deprée?
According to the CBE register, the registered office of Pharma Deprée is in 3120 Tremelo.
What is the equity of Pharma Deprée?
At the close of the 2025 financial year, the equity of Pharma Deprée amounts to 257,179 €, a solvency of 27.4% of total assets.
Who manages Pharma Deprée?
The register lists 1 active mandates at Pharma Deprée. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Deprée
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →